The Kabuki Syndrome market growth trajectory reflects fundamental shifts in rare disease research prioritization, diagnostic technology accessibility, and healthcare policy frameworks supporting genetic disorder management. Growth acceleration is substantially attributed to revolutionary advances in genomic sequencing technologies that have dramatically reduced diagnostic odysseys...